Share on:

Pharmacy Practice Residency in Oncology (Minnesota)

Pharmacy Practice Residency in Oncology Post Graduate Year 2 (PGY2) - Rochester, Minn.

Program Description
Mayo Clinic College of Medicine in Rochester, Minn., offers a one-year postgraduate PGY-2 Pharmacy Practice Residency in Oncology. The program is designed for practitioners who desire advanced training in oncology pharmacotherapy.

This program provides the high-quality didactic and clinical experiences needed to create a well-rounded, fully competent oncology pharmacist. As an oncology pharmacy practice resident you will:

  • Develop expertise, knowledge and skills in oncology therapeutics.
  • Contribute to an interdisciplinary health-care team offering patient-specific therapeutic interventions to treat, cure, rehabilitate and alleviate medical conditions and diseases unique to cancer patients.
  • Enhance your skills in conducting clinical research.
  • Strengthen your communication skills by presenting formal and informal lectures, writing professional manuscripts and leading interdisciplinary discussions.

Mayo Clinic's Oncology Pharmacy Practice Residency provides opportunities for advanced training in all areas related to cancer. During each rotation you will work closely with your primary preceptor, highly qualified pharmacists, as well as oncology physicians and other allied health professionals.

Accreditation
Mayo School of Health Sciences' Oncology Pharmacy Practice Residency is accredited by the American Society of Health-System Pharmacists (ASHP).

Facilities
The Mayo Clinic campus in Rochester is comprised of an extensive outpatient complex, Saint Marys Hospital, Rochester Methodist Hospital, as well as multiple research and education facilities. The Mayo Clinic Cancer Center is a National Cancer Institute (NCI)-designated comprehensive cancer center with an international presence. Nearly 20,000 new cancer patients are treated at Mayo Clinic every year, making it one of the largest cancer treatment facilities in the nation. Hundreds of clinical trials are available for patients, led by Mayo scientists, including the North Central Cancer Treatment Group, Phase I Program, Phase II Consortium and Cancer Prevention Network. Additional trials are also available through cooperative research affiliations and collaborations with the NCI and other clinical trial groups.

Certification
Upon successful completion of your PGY-2 Pharmacy Practice Residency in Oncology, you will receive a Certificate of Completion from the Mayo College of Medicine, Mayo School of Health Sciences. Graduates are eligible to take the Board of Pharmaceutical Specialties' examinations in oncology pharmacy and/or pharmacotherapy.

Hours
For the majority of the residency, your learning schedule will include ten-hour days, five days per week. In addition, you will have a staffing component of approximately 16 hours per month.

Positions
Each year, Mayo School of Health Sciences welcomes one to two residents to its Pharmacy Practice Residency in Oncology at Mayo Clinic in Rochester. This ensures you will receive a comprehensive educational experience with close one-on-one instruction. There are currently a total of ten pharmacy residents at Mayo Clinic in Rochester.

  • ART544613